0.0693
price down icon0.36%   -0.0003
 
loading
전일 마감가:
$0.069
열려 있는:
$0.069
하루 거래량:
2.84M
Relative Volume:
0.40
시가총액:
$865.44K
수익:
-
순이익/손실:
$-53.12M
주가수익비율:
-0.000637
EPS:
-108.8
순현금흐름:
$-15.86M
1주 성능:
+15.55%
1개월 성능:
-30.41%
6개월 성능:
-98.20%
1년 성능:
-98.57%
1일 변동 폭
Value
$0.0512
$0.071
1주일 범위
Value
$0.0512
$0.071
52주 변동 폭
Value
$0.0502
$21.40

블루 워터 백신 Stock (ONCO) Company Profile

Name
명칭
Onconetix Inc
Name
전화
513-620-4101
Name
주소
201 E. FIFTH STREET, CINCINNATI
Name
직원
12
Name
트위터
Name
다음 수익 날짜
2024-05-30
Name
최신 SEC 제출 서류
Name
ONCO's Discussions on Twitter

ONCO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ONCO
Onconetix Inc
0.0689 865.44K 0 -53.12M -15.86M -108.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
490.40 125.74B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
600.71 61.57B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
615.65 36.40B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.97 30.36B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
246.15 24.89B 3.81B -644.79M -669.77M -6.24

블루 워터 백신 주식(ONCO)의 최신 뉴스

pulisher
Apr 22, 2025

Take off with Onconetix Inc (ONCO): Get ready for trading - Sete News

Apr 22, 2025
pulisher
Apr 22, 2025

ONCO’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Form 424B3Prospectus [Rule 424(b)(3)] - ADVFN

Apr 22, 2025
pulisher
Apr 21, 2025

Form 8-KCurrent report - ADVFN

Apr 21, 2025
pulisher
Apr 21, 2025

Onconetix faces third delisting threat since 2022 IPOCincinnati Business Courier - The Business Journals

Apr 21, 2025
pulisher
Apr 18, 2025

Onconetix faces Nasdaq delisting over low share price By Investing.com - Investing.com India

Apr 18, 2025
pulisher
Apr 18, 2025

Onconetix faces Nasdaq delisting over low share price - Investing.com

Apr 18, 2025
pulisher
Apr 08, 2025

ONCO stock plunges to 52-week low, touches $0.06 - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

ONCO stock plunges to 52-week low, touches $0.06 By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

Cincinnati's Onconetix pursuing merger deal with drug development firm - The Business Journals

Apr 08, 2025
pulisher
Apr 08, 2025

Onconetix Sets Stage For Potential Business Combination With Ocuvex Therapeutics - MarketScreener

Apr 08, 2025
pulisher
Apr 08, 2025

Onconetix eyes Ocuvex in potential merger to expand portfolio By Investing.com - Investing.com India

Apr 08, 2025
pulisher
Apr 08, 2025

Onconetix, Ocuvex Therapeutics Sign Letter of Intent for Potential Merger; Shares Up Pre-Bell - marketscreener.com

Apr 08, 2025
pulisher
Apr 08, 2025

Onconetix Inks Letter Of Intent For Potential Business Combination With Ocuvex - Nasdaq

Apr 08, 2025
pulisher
Apr 08, 2025

Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc. - The Manila Times

Apr 08, 2025
pulisher
Apr 08, 2025

Max Alderman, Partner at FE International, Recognized as a NACVA 2024 30 Under Thirty Honoree - The Manila Times

Apr 08, 2025
pulisher
Apr 08, 2025

Onconetix eyes Ocuvex in potential merger to expand portfolio - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Target Corp (TGT) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com

Apr 08, 2025
pulisher
Apr 08, 2025

Major Pipeline Expansion: Onconetix to Acquire FDA-Approved Eye Drug in Ocuvex Deal - Stock Titan

Apr 08, 2025
pulisher
Apr 05, 2025

Another top executive departs Cincinnati public firm - WKRC

Apr 05, 2025
pulisher
Apr 04, 2025

Onconetix executive chairman resigns in latest leadership exit; interim CFO named new top leader - The Business Journals

Apr 04, 2025
pulisher
Apr 03, 2025

Onconetix Names Interim CFO Karina Fedasz as Interim CEO - MarketWatch

Apr 03, 2025
pulisher
Apr 03, 2025

Onconetix Appoints Karina Fedasz as Interim CEO - TipRanks

Apr 03, 2025
pulisher
Apr 01, 2025

Onconetix Delays Yearly Report Filing - TipRanks

Apr 01, 2025
pulisher
Mar 27, 2025

Pre-market Movers: RGLS, SLNO, OCEA, OSRH... - RTTNews

Mar 27, 2025
pulisher
Mar 25, 2025

Onconetix claims validation of prostate cancer test Proclarix in Danish cohort - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort - GlobeNewswire

Mar 25, 2025
pulisher
Mar 24, 2025

Onconetix reveals Proclarix’s clinical performance at EAU congress - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Onconetix Announces Successful Clinical Validation Of Proclarix For Prostate Cancer In Danish Cohort - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

Onconetix reveals Proclarix’s clinical performance at EAU congress By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Onconetix Inc. Presents Promising Clinical Data for Proclarix® at 2025 EAU Congress - Nasdaq

Mar 24, 2025
pulisher
Mar 21, 2025

Onconetix Inc (NASDAQ: ONCO): Blank Check On Growth? - Stocks Register

Mar 21, 2025
pulisher
Mar 19, 2025

Onconetix Announces New Clinical Data for its Innovative - GlobeNewswire

Mar 19, 2025
pulisher
Mar 19, 2025

Onconetix to Present Proclarix at EAU Congress 2025 - TipRanks

Mar 19, 2025
pulisher
Mar 19, 2025

Onconetix, Inc. to Present Proclarix Study Results at 2025 EAU Congress in Madrid - Nasdaq

Mar 19, 2025
pulisher
Mar 19, 2025

Groundbreaking 800-Patient Study Shows How Onconetix's Proclarix Test Prevents Unnecessary Prostate Biopsies - StockTitan

Mar 19, 2025
pulisher
Mar 19, 2025

ONCO stock plunges to 52-week low, touches $0.12 By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

ONCO stock plunges to 52-week low, touches $0.12 - Investing.com India

Mar 18, 2025
pulisher
Mar 03, 2025

Onconetix taps industry veteran as executive chairman amid CEO resignation - The Business Journals

Mar 03, 2025
pulisher
Feb 28, 2025

Onconetix names new executive chairman, appoints board member By Investing.com - Investing.com Australia

Feb 28, 2025
pulisher
Feb 28, 2025

Onconetix names new executive chairman, appoints board member - Investing.com India

Feb 28, 2025
pulisher
Feb 28, 2025

Onconetix Announces Leadership Changes and New Appointments - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Onconetix Says Ralph Schiess Resigns As Interim CEO And Chief Science Officer -February 28, 2025 at 05:35 pm EST - Marketscreener.com

Feb 28, 2025
pulisher
Feb 19, 2025

Onconetix secures new financing, appoints auditor, sees executive exit By Investing.com - Investing.com South Africa

Feb 19, 2025
pulisher
Feb 18, 2025

Onconetix secures new financing, appoints auditor, sees executive exit - Investing.com

Feb 18, 2025
pulisher
Feb 18, 2025

Onconetix Announces Promissory Note Agreement with Keystone - TipRanks

Feb 18, 2025
pulisher
Feb 16, 2025

Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - MSN

Feb 16, 2025
pulisher
Feb 05, 2025

Investing in Onconetix Inc (ONCO) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

Onconetix Inc (ONCO) Stock: A Year of Decreases and Increases - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

Daily Market Movement: Onconetix Inc (ONCO) Sees a 11.91 Increase, Closing at 0.61 - The Dwinnex

Feb 04, 2025
pulisher
Jan 29, 2025

Onconetix files to sell 50M shares of common stock for holders - MSN

Jan 29, 2025

블루 워터 백신 (ONCO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.39
price down icon 0.63%
$68.60
price down icon 0.25%
$32.01
price down icon 0.09%
$34.64
price down icon 7.28%
$114.80
price down icon 4.57%
biotechnology ONC
$248.25
price down icon 2.59%
자본화:     |  볼륨(24시간):